chr14-21569816-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005465.2(OR10G3):c.929C>A(p.Pro310Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000171 in 1,461,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005465.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10G3 | NM_001005465.2 | c.929C>A | p.Pro310Gln | missense_variant | 2/2 | ENST00000641040.1 | NP_001005465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10G3 | ENST00000641040.1 | c.929C>A | p.Pro310Gln | missense_variant | 2/2 | NM_001005465.2 | ENSP00000493245.1 | |||
OR10G3 | ENST00000641185.1 | c.929C>A | p.Pro310Gln | missense_variant | 3/3 | ENSP00000492973.1 | ||||
OR10G3 | ENST00000641655.1 | n.557C>A | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251126Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135728
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461496Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727066
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2024 | The c.929C>A (p.P310Q) alteration is located in exon 1 (coding exon 1) of the OR10G3 gene. This alteration results from a C to A substitution at nucleotide position 929, causing the proline (P) at amino acid position 310 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at